来自MSN2 个月
Azvudine beats paxlovid in reducing COVID-19 deaths
A large-scale study reveals azvudine’s comparable efficacy to Paxlovid, fewer adverse effects, and potential antitumor benefits in patients with liver cancer. Study: Real‐world effectiveness ...
TASS2 年
China’s oral anti-COVID drug Azvudine covered by medical insurance in Hainan
According to Hainan Daily, the decision was made in mid-August after COVID-19 outbreak was reported on the island HAIKOU /China/, August 22. /TASS/. The Health Insurance Administration of South ...